Press Releases

June 13 2013

The SCOTUS decision represents a departure from judicial and PTO precedent supporting...

May 14 2013

BIO welcomes the unanimous Supreme Court decision in Bowman v. Monsanto, in which the Court...

September 8 2011

Biotechnology Industry Organization (BIO) President and CEO Jim Greenwood released the...

June 23 2011

BIO President and CEO Jim Greenwood released a statement on the passage of The Leahy-Smith...

June 21 2011

WASHINGTON, D.C. (Tuesday, June 21, 2011) - Biotechnology Industry Organization (BIO) President...

May 3 2011

BIO announces its selection of Senator Patrick Leahy (D-VT) as Legislator of the Year for 2010...

April 15 2011

BIO President and CEO Jim Greenwood releases statement regarding the America Invents Act, H.R...

March 31 2011

BIO praises House Judiciary Committee Chairman Lamar Smith (R-TX) for his introduction of a...

March 8 2011

BIO commends the Senate for its overwhelming passage of the America Invents Act by a vote of...

February 3 2011

BIO appreciates the continued dedication of Chairman Patrick Leahy (D-VT), Ranking Member...

January 28 2011

BIO appreciates the dedication of Chairman Leahy, Ranking Member Charles Grassley (R-IA),...

March 15 2010

David Kappos, Director of the U.S. Patent and Trademark Office and Under Secretary of Commerce...

March 4 2010

BIO President and CEO Jim Greenwood released the following statement on the manager’s...

March 3 2009

Patent reform should promote innovation and improve patent quality.

September 7 2007

Notes Strong, Bipartisan Opposition in the House, Will Continue to Work with the Senate to...

July 19 2007

Thanks chairmen for improvements made during markup.

April 2 2014
BIO joins coalition letter to Chairman Patrick Leahy and Ranking Member Chuck Grassley expressing serious concerns with the direction of patent legislation.
October 16 2013
BIO appreciates this fourth opportunity to formally respond to the Colombian Ministry of Health’s Draft Decree on Regulatory Requirements for the Registry of Medicines of Biological Origin and we refer you to our previous comments filed to the Colombian Ministry of Health on April 24th 2012, June 12th 2012 and February 21st 2013 for background about BIO and its interest in this Decree. 
July 8 2013
As the Mexican government looks to establish a pathway to market for biosimilar biological products, BIO offers the following important considerations to ensure patient safety, as well as continued innovation in the life sciences industry.
June 19 2013
We understand the challenges that India faces with respect to healthcare and the innovative biotechnology industry stands ready to work with India to help address them.  
June 7 2013
BIO applauds the government of Brazil for taking steps towards developing regulatory requirements to ensure patients suffering from rare diseases have access to treatment.   
December 3 2013
BIO issued the following statement regarding the Innovation Act (H.R. 3309), as reported by the House Judiciary Committee.
June 13 2013
The SCOTUS decision represents a departure from judicial and PTO precedent supporting patentability of DNA molecules. The decision could create business uncertainty for a range of inventions.
May 14 2013
BIO welcomes the unanimous Supreme Court decision in Bowman v. Monsanto, in which the Court confirms that biotechnology seed is entitled to the same protections as other inventions under the patent law.
September 8 2011
Biotechnology Industry Organization (BIO) President and CEO Jim Greenwood released the following statement on the passage of The Leahy-Smith America Invents Act, H.R. 1249, by the U.S. Senate.
June 23 2011
BIO President and CEO Jim Greenwood released a statement on the passage of The Leahy-Smith America Invents Act, H.R. 1249, by the House of Representatives.